Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment | BMJ Paediatrics Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Topic collections
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Dermatology

Original research

Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

	Abstract	Full	Pdf
Sep 2021	125	122	36
Oct 2021	151	148	352
Nov 2021	80	81	33
Dec 2021	70	70	16
Jan 2022	49	50	23
Feb 2022	41	41	18
Mar 2022	104	108	19
Apr 2022	88	88	15
May 2022	95	96	22
Jun 2022	120	121	13
Jul 2022	125	129	17
Aug 2022	118	118	47
Sep 2022	60	62	37
Oct 2022	52	52	18
Nov 2022	39	39	17
Dec 2022	41	43	7
Jan 2023	60	64	23
Feb 2023	104	111	37
Mar 2023	116	118	17
Apr 2023	61	63	15
May 2023	81	83	18
Jun 2023	80	82	23
Jul 2023	63	68	19
Aug 2023	89	91	26
Sep 2023	100	104	16
Oct 2023	89	92	27
Nov 2023	74	79	16
Dec 2023	65	66	7
Jan 2024	22	22	10
Feb 2024	49	50	9
Mar 2024	51	52	16
Total	2462	2513	969